Due to the COVID-19 pandemic, Danish Medicines Agency inspections have been put on hold and this includes for cannabis producers.
This move could mean that Denmark’s domestic medical cannabis businesses could face more delays in getting product to market as producers await certificates of compliance from the health agency.
The Danish Medicines Agency is the one that issues certificates for cannabis-producing companies to confirm compliance with national regulations on the manufacture of marijuana in the pilot program.
A certificate from the agency also confirms compliance with Good Manufacturing Practice for medicines, which is needed before a company can export medical marijuana products to other markets in the European Union.
According to Rikke Jakobsen of the nongovernmental organization Cannabis Denmark, inspections are expected to resume within two months.
Jakobsen said Denmark was one of the few countries in Europe that took early action to deal with the virus. “We expect a gradual reopening over the summer,” said Jakobsen.
Denmark has reported 6,511 infections and 299 deaths from COVID-19 as of April 14th.
